InvestorsHub Logo
icon url

mrmainstreet

07/21/22 12:03 PM

#383996 RE: iwanderer #383994

Why is it so hard to understand that those of us buying under $2 think the stock will provide a solid ROI from here? The company has a safe, approved, affordable drug with good margins.

They have stabilized the US scripts IMO with these exclusivity deals, and are getting EU/ROW built up. Denner is on board as a 6% shareholder and his track record is interesting as an activist investor.

I know you're working the board hard to talk your book, but surely it can't be that surprising that buyers think there is value at these levels.
icon url

ggwpq

07/21/22 12:30 PM

#384000 RE: iwanderer #383994

i, the question is why are you still posting here without anything insightful to contribute. Do you have a sadistic personality? You should take your trading "talent" to other stocks instead of scalping pennies in AMRN.
icon url

Birdbrain Ideas

07/21/22 1:09 PM

#384007 RE: iwanderer #383994

The person who posted that Titanic message has the attitude that Amarin is racing to bankruptcy and all investors will lose everything. But that's highly unlikely to be the case. In fact, the company was managing to stay afloat and lose very little each quarter until last quarter. And it does seem to be taking drastic action with the further staffing reduction and $100 million slashing of expenses.

At some point, some revenue will begin trickling in from the launch of sales in multiple European countries and we will get a clearer idea of what the potential is.

The best chances for a decent catalyst, I think, are:

1) Real sales in European countries
2) Any kind of partnership with Big Pharma akin to what Pfizer is doing for Vascepa in Canada.
3) Positive results in the Alzheimer's trial slated to end in February. I know it's a small study of only about 150 people, but it takes very little in that area to create great interest. Just look at SAVA and AVXL. I don't hold out great hope for this trial though since the end date was already extended by 15 months. That tells me that they're probably having trouble seeing significant results and are hoping that a wider window improves the chances of measurable results.
icon url

ilovetech

07/21/22 11:07 PM

#384041 RE: iwanderer #383994

Wanderer - I have to agree with you. I can't imagine adding a single new share. Especially as someone whose been here since 2016. I just want to recover as much as possible and not look back. So I have no choice but to keep track of anything positive in hopes we achieve that end.

ILT